Source: Cells. Unidades: FM, IQ
Subjects: NEOPLASIAS MAMÁRIAS, PROTEÔMICA
ABNT
SANTANA, Monique de Fátima Mello et al. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease. Cells, v. 13, p. 1-19 art. 1327, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cells13161327. Acesso em: 01 nov. 2024.APA
Santana, M. de F. M., Sawada, M. I. B. A. C., Souza Junior, D. R. de, Giacaglia, M. B., Reis, M., Xavier, J., et al. (2024). Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease. Cells, 13, 1-19 art. 1327. doi:10.3390/cells13161327NLM
Santana M de FM, Sawada MIBAC, Souza Junior DR de, Giacaglia MB, Reis M, Xavier J, Giannella MLC, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease [Internet]. Cells. 2024 ; 13 1-19 art. 1327.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.3390/cells13161327Vancouver
Santana M de FM, Sawada MIBAC, Souza Junior DR de, Giacaglia MB, Reis M, Xavier J, Giannella MLC, Soriano FG, Gebrim LH, Ronsein GE, Passarelli M. Proteomic profiling of HDL in newly diagnosed breast cancer based on tumor molecular classification and clinical stage of disease [Internet]. Cells. 2024 ; 13 1-19 art. 1327.[citado 2024 nov. 01 ] Available from: https://dx.doi.org/10.3390/cells13161327